6Th Congress of Ascnp Ascnp6th Congress of Asian College of Neuropsychopharmacology Program & Abstract Book
Total Page:16
File Type:pdf, Size:1020Kb
6th Congress of AsCNP AsCNP6th Congress of Asian College of Neuropsychopharmacology Program & Abstract Book Neuropsychopharmacology to the next generation: New wave from Asia October 11-13, 2019 Fukuoka International Congress Center Fukuoka, Japan Fukuoka Sunpalace Hotel & Hall Chair: Kazutaka Ikeda (Tokyo Metropolitan Institute of Medical Science) Vice Chairs: Kazutaka Shimoda (Dokkyo Medical University) Toshiyuki Someya (Niigata University) Alliance Head: Hiroyuki Uchida (Keio University) Secretary: Shinya Kasai (Tokyo Metropolitan Institute of Medical Science) Fukuoka, Japan Oct. 11 - 13, 2019 Program & Abstract Book 6th Congress of AsCNPAsian College of Neuropsychopharmacology Neuropsychopharmacology to the next generation: New wave from Asia October 11-13, 2019 Fukuoka International Congress Center Fukuoka, Japan Fukuoka Sunpalace Hotel & Hall Chair: Kazutaka Ikeda (Tokyo Metropolitan Institute of Medical Science) Vice Chairs: Kazutaka Shimoda (Dokkyo Medical University) Toshiyuki Someya (Niigata University) Alliance Head: Hiroyuki Uchida (Keio University) Secretary: Shinya Kasai (Tokyo Metropolitan Institute of Medical Science) Joint Annual Meetings JSCNP JSNP 29th Annual Meeting of 49th Annual Meeting of Japanese Society of Japanese Society of Clinical Neuropsychopharmacology Neuropsychopharmacology Chair: Reiji Yoshimura Chair: Hisatsugu Miyata (University of Occupational and Environmental Health) (Jikei University School of Medicine) Host Asian College of Neuropsychopharmacology (AsCNP) Supporting Organizations Fukuoka City / The International College of Neuropsychopharmacology / Japan Epilepsy Society / Japan National Tourism Organization (JNTO) / Japan Neuroscience Society / Japan Pharmaceutical Association / Japan Pharmaceutical Manufacturers Association / Japan Psychiatric Hospitals Association / Japan Society of Pain Clinicians / Japan Tourism Agency / Japanese Association of Cardiovascular Pharmacology / Japanese Medical Society of Alcohol and Addiction Studies / The Japanese Neuropsychiatric Association / The Japanese Pharmacological Society / Japanese Society of Anesthesiologists / Japanese Society of Anxiety and Related Disorders / Japanese Society of Biological Psychiatry / The Japanese Society of Clinical Pharmacology and Therapeutics / Japanese Society of General Hospital Psychiatry / Japanese Society of Hospital Pharmacists / Japanese Society of Mood Disorders / The Japanese Society for Neurochemistry / Japanese Society of Neurology / Japanese Society for Psychiatric Diagnosis / The Japanese Society of Psychiatry and Neurology / Japanese Society of Schizophrenia Research / Japanese Society of Sleep Research / Kyushu Psychiatric Hospitals Association / The Molecular Biology Society of Japan / The Physiological Society of Japan / Union of Brain Science Associations in Japan Contents Greetings 4 Organizers 5 Access 8 Floor Plan 9 Program at a Glance 12 Information for Participants 18 Information for Chairs and Presenters 22 Pre-Congress Meetings 25 Special Lecture 29 Symposium 41 Luncheon Seminar 237 Sponsored Symposium 249 Award Lecture 271 Oral Session 285 Poster Session 307 ASEAN Pre-Congress Meeting 385 October 11-13, 2019 – Fukuoka, Japan 3 Greetings It is our great pleasure to organize the 6th Asian College of Neuropsychopharmacology (AsCNP) Congress that is held in Fukuoka, Japan, on October 11-13, 2019. The main theme of the congress is “Neuropsychopharmacology to the next generation: New wave from Asia.” Pharmacotherapy for the treatment of neuropsychiatric disorders should be developed further in Asia where robust economic expansion has occurred. Most medications for the treatment of central nervous system disorders have been developed for the European and American populations but are not always suitable for Asian populations. Medications should be developed specifically for Asians, including appropriate dosage and usage. The AsCNP2019 Congress seeks to advance neuropsychopharmacology to the next generation in Asia. AsCNP was founded in 2008, based on the need to elucidate the mechanisms that underlie the effects of medications for the treatment of central nervous system disorders, develop new medications, and appropriately utilize such medications in Asia. The mission of AsCNP is to encourage research, facilitate the communication of ideas in converging disciplines of neuropsychopharmacology in Asia, develop pharmacotherapies for the treatment for psychiatric disorders, provide education and training opportunities, and empower patients and their families with scientific knowledge. The AsCNP Congress was convened in Kyoto in 2009, Seoul in 2011, Beijing in 2013, Taipei in 2015, and Bali in 2017. AsCNP currently has more than 3000 members. The AsCNP2019 Congress will be held in conjunction with the annual meetings of the Japanese Society of Neuropsychopharmacology (JSNP) and Japanese Society of Clinical Neuropsychopharmacology (JSCNP). Other AsCNP member societies are also planning joint events at the AsCNP2019 Congress. Many scientists, clinicians, industry researchers, governmental officials, and invited world-renowned leaders will gather at the congress to advance neuropsychopharmacology in Asia. We look forward to welcoming you in Fukuoka in 2019. Kazutaka Ikeda Chair, 2019 AsCNP Congress Kazutaka Shimoda Toshiyuki Someya Vice Chairs, 2019 AsCNP Congress 4 6th Congress of Asian College of Neuropsychopharmacology (AsCNP) Organizers Organizers of 6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019) Chair: Kazutaka Ikeda (Tokyo Metropolitan Institute of Medical Science) Vice Chairs: Kazutaka Shimoda (Dokkyo Medical University) Toshiyuki Someya (Niigata University) Alliance Head: Hiroyuki Uchida (Keio University) Secretary: Shinya Kasai (Tokyo Metropolitan Institute of Medical Science) Organizing Committee Chair: Shigenobu Kanba (Kyushu Univeristy) Organizing Committee Members: Tatsuo Akechi (Nagoya City University) Manabu Ikeda (Osaka University) Satoshi Asakura (Hokkaido University) Masashi Ikeda (Fujita Health University) Masato Asanuma (Okayama University) Toshiya Inada (Nagoya University) Hazime Baba (Juntendo University) Ataru Inagaki (Aoyama Gakuin University) Won-Myong Bahk (The Catholic University of Korea, Korea) Koki Inoue (Osaka City University) Ya Mei Bai (National Yang-Ming University / Taipei Veterans General Hospital, Taiwan) Takeshi Inoue (Tokyo Medical University) Haruhiko Bito (The University of Tokyo) Masako Iseki (Juntendo University) Eric Yu Hai Chen (The University of Hong Kong, China) Yasushi Ishida (University of Miyazaki) Shigeru Chiba (Asahikawa Medical University) Kumiko Ishige (Nihon University) Lih-Chu Chiou (National Taiwan University, Taiwan) Jun Ishigooka (Yoyogi Mental Clinic / Institute of CNS Pharmacology) Yuan-Hwa Chou (Taipei Veterans General Hospital, Taiwan) Takeshi Ishihara (Kawasaki Medical School) Young-Chul Chung (Chonbuk National University Medical School, Korea) Masanari Itokawa (Tokyo Metropolitan Institute of Medical Science) Brian Dean (Swinburne University, Australia) Akira Iwanami (Showa University) Nagafumi Doi (Ibaraki Prefectural Medical Center of Psychiatry) Katsunori Iwasaki (Fukuoka University) Ken-ichi Fukuda (Tokyo Dental Collage) Nakao Iwata (Fujita Health University) Masato Fukuda (Gunma University) Nobuhisa Iwata (Nagasaki University) Kohji Fukunaga (Tohoku University) Masaomi Iyo (Chiba University) Toshiaki A. Furukawa (Kyoto University) Hiroshi Kadotani (Shiga University of Medical Science) Tomoyuki Furuyashiki (Kobe University) Mitsuhiro Kamata (Tokorozawa Jikou Hospital) Hitoshi Hashimoto (Osaka University) Yasuhiro Kaneda (Iiwaki Clinic) Kenji Hashimoto (Chiba University) Shuji Kaneko (Kyoto University) Ryota Hashimoto (National Center of Neurology and Psychiatry) Kosuke Kanemoto (Aichi Medical University) Nobutaka Hattori (Juntendo University) Kiyoto Kasai (The University of Tokyo) Yanling He (Shanghai Jiao Tong University, China) Masaki Kato (Kansai Medical University) Teruhiko Higuchi (Rokubancho Mental Clinic) Nobumasa Kato (Institute of Neuro-Psychiatry) Hirokazu Hirai (Gunma University) Tadafumi Kato (RIKEN) Masayuki Hiramatsu (Meijo University) Chiaki Kawanishi (Sapporo Medical University) Yoshio Hirayasu (Yokohama City University) Hiroaki Kawasaki (Fukuoka University) Naoyuki Hironaka (LSI Medience Corp.) Satoshi Kida (Tokyo University of Agriculture) Hikaru Hori (University of Occupational and Environmental Health) Tetsuro Kikuchi (Otsuka Pharmaceutical Co., Ltd.) Jun Horiguchi (Shimane University) Toshiaki Kikuchi (Japan Agency for Medical Research and Development) Hiroshi Ichinose (Tokyo Institute of Technology) Chan-Hyung Kim (Yonsei University, Korea) Jun-ichi Iga (Ehime University) Euitae Kim (Seoul National University, Korea) Kazutaka Ikeda (Tokyo Metropolitan Institute of Medical Science) Toshihiko Kinoshita (Kansai Medical University) October 11-13, 2019 – Fukuoka, Japan 5 Taro Kishi (Fujita Health University) Shin-Ichi Niwa (Fukushima Medical University) Taishiro Kishimoto (Keio University) Yukihiro Noda (Meijo University) Toshifumi Kishimoto (Nara Medical University) Yasuyuki Nomura (Kurume University) Kiyoyuki Kitaichi (Gifu Pharmaceutical University) Shusuke Numata (Tokushima University) Kazuto Kobayashi (Fukushima Medical University) Tetsuro Ohmori (Tokushima University) Fumitoshi Kodaka (Jikei University School of Medicine) Yukihiro Ohno (Osaka University of Pharmaceutical Sciences) Tsuyoshi Koide (National Institute of Genetics) Toshihisa Ohtsuka (University of Yamanashi) Shuichi Koizumi